Safety Profile of HTX-019 Administered as an Intravenous Infusion in Patients With Cancer: A Retrospective Analysis. [electronic resource]
Producer: 20191231Description: 260-263 p. digitalISSN:- 1539-0667
- Aged
- Antiemetics -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Aprepitant -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Male
- Nausea -- chemically induced
- Neoplasms -- complications
- Neurokinin-1 Receptor Antagonists -- administration & dosage
- Retrospective Studies
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.